Summary of clinical results

AVENE
comedomed+

Tolerability of use in pre-adolescents with mild to moderate facial acne

Tolerance in pre-adolescents

Population

16 subjects aged 9 to 11

64% girls, 44% boys

100% mild to moderate facial acne with at least 5 non-inflammatory lesions

Application of COMEDOMED+ intense anti-blemish treatment

Face application 2x/day for 21 days

Evaluation criteria

Dermatological controls

Results

Good skin tolerance

 

 

More summaries of clinical results